Doisynolic acid
Doisynolic Acid is a synthetic, non-steroidal estrogen that was first synthesized in the early 20th century. It is a member of the stilbene group, which includes several other synthetic and natural estrogens. Doisynolic acid was primarily used in the treatment of menopausal symptoms and as a component of some oral contraceptives. However, its use has declined over the years due to the development of more effective and safer estrogenic compounds.
Chemical Structure and Synthesis
Doisynolic acid, chemically known as 4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol, is synthesized through the condensation of ethylstilbestrol with phenol under alkaline conditions. This process results in a compound that exhibits estrogenic activity by mimicking the action of endogenous estrogens in the body.
Mechanism of Action
The estrogenic effects of doisynolic acid are mediated through its binding to estrogen receptors (ERs) in target tissues. This binding induces a conformational change in the receptor, leading to the activation of estrogen-responsive genes. These genes are involved in a wide range of physiological processes, including the regulation of the menstrual cycle, maintenance of pregnancy, and development of secondary sexual characteristics.
Clinical Uses
Historically, doisynolic acid was used in the treatment of various estrogen-related conditions, including:
- Menopausal symptoms: Hot flashes, vaginal dryness, and osteoporosis prevention.
- Oral contraceptives: As a component of some early formulations.
- Hormone replacement therapy (HRT): For women with estrogen deficiency.
Safety and Side Effects
Like other estrogens, doisynolic acid can cause a range of side effects, including an increased risk of thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism. It may also increase the risk of certain types of cancer, such as breast and endometrial cancer, especially with long-term use.
Current Status
The use of doisynolic acid has largely been superseded by newer and safer estrogenic compounds. Its use today is limited, and it is primarily of historical interest in the study of synthetic estrogens and their development.
See Also
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
